A Plea to Let Patients With Cancer “Just Eat”
Restricted diets are commonplace at many cancer centers, but there is no evidence that they reduce a patient’s risk of infection.
Prior Authorization Is Top Administrative Challenge of 2023
Prior authorization costs clinicians time and money. Heading into 2023, prior authorization was listed as a top administrative challenge.
Nursing Education Can Be a Lifelong Marathon. Are You Ready for the Race?
Nursing education should be viewed as a long-course endeavor rather than a sprint.
Considerations for Premenopausal Women With TNBC
Triple-negative breast cancer often occurs in women younger than 40.
Updates in Triple-Negative Breast Cancer Treatment
Oncology nurses provide perspective on the changing standards of care for patients with triple-negative breast cancer.
Preparing Patients for CAR T-Cell Therapy With Confidence
As the therapy continues to evolve, best nursing practices become more nuanced.
Futibatinib Approval Ushers in Targeted Therapy Option for Patients With Unresectable, Intrahepatic FGFR2-Positive Cholangiocarcinoma
Osheka Hansel, APRN, discusses the recent approval of futibatinib (Lytgobi) for patients with unresectable, locally advanced or metastatic intrahepatic FGFR2-positive cholangiocarcinoma.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512